A pilot of study of effects of a daily foods containing plant extracts in patients with mild cognitive impairment due to Alzheimer's disease
- Conditions
- MCI
- Registration Number
- JPRN-UMIN000052043
- Lead Sponsor
- Kanagawa Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Not provided
(1) Patients who are Alzheimer's disease (AD) with CDR 1 or over, and FAST stage 4 or over (2) Patients who are Mild Cognitive Impairment (MCI) not due to AD (3) An adult males and females under 45 or over 80 years of age, and have comorbidity or history of malignancies, serious liver disease, or other serious internal disorder (4) Patients who take drugs, quasi-drug or health food on a daily basis, such as Docosahexaenoic Acid (DHA), eicosapentaenoic acid (EPA), Ginkgo biloba extract, linseed oil, tocotrienols, tocopherols, astaxanthin, Gamma Amino Butyric Acid (GABA), phosphatidylserine, and plasmalogen. (5) Patients who have extremely irregular dietary habits (7) Patients who have excessive alcohol-drinking or (8) Patients who are smoker (9) Patients who have soy allergy (10) Patients who have plan to participate in other trial during scheduled period in this trial (11) Patients judged as unsuitable for the study by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method